Repligen Co. (NASDAQ:RGEN) Insider Trading Activity – CEO Sold 14,550 shares of Stock

ME Staff
-
0

Insider Trading Activity For Repligen Co. (NASDAQ:RGEN)

Anthony Hunt , CEO of Repligen Co. (NASDAQ:RGEN) reportedly Sold 14,550 shares of the company’s stock at an average price of 59.63 for a total transaction amount of $867,616.50 SEC Form

Insider Trading History For Repligen Co. (NASDAQ:RGEN)

  • On 8/16/2012 Michael A Griffith, Director, bought 2,000 with an average share price of $4.88 per share and the total transaction amounting to $9,760.00.
  • On 9/21/2012 Glenn L Md Cooper, Director, bought 10,000 with an average share price of $6.09 per share and the total transaction amounting to $60,900.00.
  • On 5/15/2013 Walter C Herlihy, CEO, sold 40,000 with an average share price of $8.97 per share and the total transaction amounting to $358,800.00.
  • On 5/15/2013 Thomas F Ryan Jr, Director, sold 86,039 with an average share price of $9.01 per share and the total transaction amounting to $775,211.39.
  • On 5/17/2013 Thomas F Ryan Jr, Director, sold 21,000 with an average share price of $8.97 per share and the total transaction amounting to $188,370.00.
  • On 6/21/2013 Karen A Dawes, Director, bought 1,000 with an average share price of $7.70 per share and the total transaction amounting to $7,700.00.
  • On 8/8/2013 James R Rusche, SVP, sold 30,000 with an average share price of $10.01 per share and the total transaction amounting to $300,300.00.

    • Analyst Ratings History For Repligen Co. (NASDAQ:RGEN)

    • On 10/2/2017 First Analysis Upgraded rating Equal Weight to Overweight with a price target of $47.00
    • On 10/19/2017 Jefferies Financial Group Reiterated Rating Hold with a price target of $40.00
    • On 7/10/2018 Stephens Boost Price Target of rating Overweight to Average with a price target of $50.00 to $55.00
    • On 7/20/2018 Citigroup Boost Price Target of rating Buy to Buy with a price target of $45.00 to $56.00
    • On 10/4/2018 Janney Montgomery Scott Reiterated Rating Fair Value to Buy
    • On 11/2/2018 JPMorgan Chase & Co. Boost Price Target of rating Overweight to Overweight with a price target of $60.00 to $70.00
    • On 11/2/2018 William Blair Reiterated Rating Outperform

    Recent Trading Activity for Repligen Co. (NASDAQ:RGEN)
    Shares of Repligen Co. closed the previous trading session at with 58.92 shares trading hands.